The Advisory Board was Downgraded to a Hold Rating at Canaccord Genuity

By Carrie Williams

In a report released today, Richard Close from Canaccord Genuity downgraded The Advisory Board (NASDAQ: ABCO) to Hold, with a price target of $54.29. The company’s shares opened today at $53.05.

According to TipRanks.com, Close is a 5-star analyst with an average return of 10.9% and a 57.2% success rate. Close covers the Services sector, focusing on stocks such as Patterson Companies Inc, Team Health Holdings, and Envision Healthcare.

Currently, the analyst consensus on The Advisory Board is Hold and the average price target is $54.26, representing a 2.3% upside.

In a report released today, Robert W. Baird also downgraded the stock to Hold with a $54 price target.

The company has a one year high of $59.50 and a one year low of $24.85. Currently, The Advisory Board has an average volume of 743K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Advisory Board Co. engages in the provision of performance improvement software and solutions to the health care and higher education industries. Its education programs support colleges and universities in enrollment management, academic programming and student learning, faculty recruitment and retention, student advising, alumni affairs and college and university operations. The company was founded by David G. Bradley in 1979 and is headquartered in Washington, DC.